After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Portfolio Pulse from Vandana Singh
Cencora Inc (NYSE:COR) has notified individuals about a data breach that occurred in February, compromising sensitive medical information. The breach involved data obtained through partnerships with pharmaceutical companies such as AbbVie Inc (NYSE:ABBV), Acadia Pharmaceuticals Inc (NASDAQ:ACAD), Bayer AG (OTC:BAYZF, OTC:BAYRY), Novartis AG (NYSE:NVS), and Regeneron Pharmaceuticals Inc (NASDAQ:REGN). The incident is part of a series of cyberattacks targeting the U.S. healthcare sector.
May 24, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cencora Inc has disclosed a data breach affecting sensitive medical information obtained through partnerships with various pharmaceutical companies. The breach may impact investor confidence and lead to regulatory scrutiny.
The disclosure of a data breach involving sensitive medical information is likely to negatively impact Cencora's stock price in the short term due to potential regulatory scrutiny and loss of investor confidence.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEUTRAL IMPACT
AbbVie Inc's partnership with Cencora has led to the exposure of sensitive medical information in a data breach. While AbbVie is not directly responsible, the association may cause minor reputational damage.
AbbVie is mentioned as a partner in the data breach, which may cause minor reputational damage. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Acadia Pharmaceuticals Inc's partnership with Cencora has led to the exposure of sensitive medical information in a data breach. The association may cause minor reputational damage.
Acadia Pharmaceuticals is mentioned as a partner in the data breach, which may cause minor reputational damage. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Bayer AG's partnership with Cencora has led to the exposure of sensitive medical information in a data breach. The association may cause minor reputational damage.
Bayer AG is mentioned as a partner in the data breach, which may cause minor reputational damage. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Novartis AG's partnership with Cencora has led to the exposure of sensitive medical information in a data breach. The association may cause minor reputational damage.
Novartis AG is mentioned as a partner in the data breach, which may cause minor reputational damage. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Regeneron Pharmaceuticals Inc's partnership with Cencora has led to the exposure of sensitive medical information in a data breach. The association may cause minor reputational damage.
Regeneron Pharmaceuticals is mentioned as a partner in the data breach, which may cause minor reputational damage. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
UnitedHealth Group Inc's Change Healthcare recently experienced a significant data breach. Although unrelated to Cencora's incident, it highlights the ongoing cybersecurity challenges in the healthcare sector.
UnitedHealth Group's Change Healthcare experienced a data breach, highlighting cybersecurity challenges in the healthcare sector. However, the direct impact on its stock price is expected to be minimal.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 30